Content by biomodal

Maja Jagodic from the Karolinska Institute uses biomodal’s novel sequencing technology to reveal the genetics and epigenetics of multiple sclerosis.

Discover how genetic and epigenetic analysis helps identify early disease biomarkers.

Profiling genetic variants and DNA methylation changes in cell free DNA could transform the detection of cancers including hepatocellular carcinoma.

A multiomic sequencing approach helps scientists capture more biomarker information through liquid biopsy.

Researchers can build models to predict gene expression by detecting and differentiating between cytosine methylation and hydroxymethylation marks in the genome.

To gather multiomic insights, researchers used to combine data from multiple workflows, but duet evoC provides more information from less sample in one workflow.